SCHEMBL26874317

SCHEMBL26874317

CC(c1cc(NC2CCCC2)n2ncc(Cl)c2n1)C1CC1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CCNT1 O60563 13/20 0.60
▸ CDK9 P50750 13/20 0.60
▸ CDK2 P24941 4/20 0.60
▸ CDK4 P11802 3/20 0.60
▸ CCND1 P24385 3/20 0.60
▸ CDK7 P50613 3/20 0.60
▸ CCNH P51946 3/20 0.60
▸ CDK1 P06493 2/20 0.60
▸ CCNA2 P20248 2/20 0.60
▸ CCNE1 P24864 2/20 0.60
▸ CCNA1 P78396 2/20 0.60
▸ CDK3 Q00526 2/20 0.60
▸ CDK6 Q00534 2/20 0.60
▸ CDK5 Q00535 2/20 0.60
▸ CDK5R1 Q15078 2/20 0.60
▸ CCNC P24863 1/20 0.60
▸ CDK8 P49336 1/20 0.60
▸ RAB9A P51151 3/20 0.43
▸ MEN1 O00255 2/20 0.43
▸ NPC1 O15118 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26872690 0.87 RAB9A (0.46) CCNT1CDK9CDK2CDK4CCND1
SCHEMBL26874256 0.85 CDK9 (0.82) CCNT1CDK9CDK2CDK4CCND1
SCHEMBL26874107 0.85 CDK9 (0.82) CCNT1CDK9CDK2CDK4CCND1
SCHEMBL26873354 0.85 CCNT1 (0.56) CCNT1CDK9CDK2CDK4CCND1
SCHEMBL26871814 0.84 CDK9 (0.44) CCNT1CDK9CDK2CDK4CCND1
SCHEMBL26873656 0.82 CCNT1 (0.58) CCNT1CDK9CDK2CDK4CCND1
SCHEMBL26874076 0.82 CCNT1 (0.58) CCNT1CDK9CDK2CDK4CCND1
SCHEMBL26874333 0.81 CCNT1 (0.60) CCNT1CDK9CDK2CDK4CCND1
SCHEMBL26871261 0.81 CDK2 (0.46) CCNT1CDK9CDK2CDK4CCND1
SCHEMBL24174228 0.79 CDK2 (0.50) CCNT1CDK9CDK2CDK4CCND1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4282868-A1 SUBSTITUTED PYRAZOLO[1,5-A]PYRIMIDINE-7-AMINE DERIVATIVE, AND COMPOSITIONS AND MEDICAL USE THEREOF Shanghai Haiyan Pharmaceutical Technology Co., Ltd (CN) 2023-11-29 — — EP disclosed
Send feedback